Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
De la Rubia, J.
11012  Ergebnisse:
Personensuche X
?
1

The genomic profiling of high-risk smoldering myeloma patie..:

Medina-Herrera, A. ; Vazquez, I. ; Cuenca, I....
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Intercomparison study between the measurement of LDL choles..:

Ruiz-Álvarez, M.J. ; Costales, T. ; García-Valdecasas, S....
Clinica Chimica Acta.  558 (2024)  - p. 117959 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Topic: AS07-Singular Entities/Subtypes/AS07c-Hereditary MDS..:

Santiago, M. ; Liquori, A. ; Gil, J.V....
Leukemia Research.  128 (2023)  - p. 107247 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH REL..:

Mateos, M ; Leleu, X ; Zamagni, E...
HemaSphere.  6 (2022)  - p. 24-25 , 2022
Link: https://doi.org/10.1097/..
 
?
5

PB1915: SOMATIC ALTERATIONS IN PATIENTS WITH INHERITED MYEL..:

Santiago Balsera, M. ; Liquori, A. ; Gil, J. V....
HemaSphere.  6 (2022)  - p. 1794-1795 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P511: RISK FACTORS AND INCIDENCE OF CARDIAC EVENTS IN A LAR..:

Boluda, B. ; Solana-Altabella, A. ; Cano, I....
HemaSphere.  6 (2022)  - p. 410-411 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P986: CYTOGENETIC DIAGNOSIS WITH NEXT-GENERATION CYTOGENETI..:

Díaz González, Á. ; Avetisyán, G. ; Mora, E....
HemaSphere.  6 (2022)  - p. 876-877 , 2022
Link: https://doi.org/10.1097/..
 
?
8

S294: LONG-TERM SAFETY AND EFFICACY OF CAPLACIZUMAB FOR ACQ..:

Scully, M. ; de la Rubia, J. ; Pavenski, K....
HemaSphere.  6 (2022)  - p. 195-196 , 2022
Link: https://doi.org/10.1097/..
 
?
9

Safety of caplacizumab in patients without documented sever..:

Besisik, S. ; Rubia, J. De La ; Peyvandi, F....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 62 , 2020
Link: https://doi.org/10.1016/..
 
?
10

OUTCOMES OF PATIENTS WITH WORSENING ACQUIRED THROMBOTIC THR..:

Scully, M. ; Rubia, J.L. ; Peyvandi, F....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 95 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Caplacizumab induces fast and durable platelet count respon..:

Kaynar, L. ; Coppo, P. ; Scully, M....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 62-63 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Résultats d'efficacité d'une analyse intégrée des essais cl..:

Coppo, P. ; Scully, M. ; Cataland, S....
La Revue de Médecine Interne.  40 (2019)  - p. A76-A77 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Résultats de l'essai de phase III HERCULES – Essai contrôlé..:

Scully, M. ; Cataland, S. ; Peyvandi, F....
La Revue de Médecine Interne.  39 (2018)  - p. A61-A62 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Consensus on the standardization of terminology in thrombot..:

Scully, M. ; Cataland, S. ; Coppo, P....
Journal of Thrombosis and Haemostasis.  15 (2017)  2 - p. 312-322 , 2017
Link: https://doi.org/10.1111/..
 
?
15

Prognostic value of antigen expression in multiple myeloma:..:

on behalf of the GEM (Grupo Español de Mieloma)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group ; Arana, P ; Paiva, B...
Leukemia.  32 (2017)  4 - p. 971-978 , 2017
Link: https://doi.org/10.1038/..
 
1-15